An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells

Mart Lamers, J Vaart, K Knoops, S (Samra) Riesebosch, Tim Breugem, Anna Mykytyn, J Beumer, Debby van Eck - Schipper, Karel Bezstarosti, CD Koopman, N Groen, RBG Ravelli, HQ Duimel, Jeroen Demmers, Georges Verjans, Marion Koopmans, MJ Muraro, PJ Peters, H Clevers, Bart Haagmans

Research output: Contribution to journalArticleAcademicpeer-review

160 Citations (Scopus)
302 Downloads (Pure)

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which may result in acute respiratory distress syndrome (ARDS), multiorgan failure, and death. The alveolar epithelium is a major target of the virus, but representative models to study virus host interactions in more detail are currently lacking. Here, we describe a human 2D air–liquid interface culture system which was characterized by confocal and electron microscopy and single-cell mRNA expression analysis. In this model, alveolar cells, but also basal cells and rare neuroendocrine cells, are grown from 3D self-renewing fetal lung bud tip organoids. These cultures were readily infected by SARS-CoV-2 with mainly surfactant protein C-positive alveolar type II-like cells being targeted. Consequently, significant viral titers were detected and mRNA expression analysis revealed induction of type I/III interferon response program. Treatment of these cultures with a low dose of interferon lambda 1 reduced viral replication. Hence, these cultures represent an experimental model for SARS-CoV-2 infection and can be applied for drug screens.

Original languageEnglish
Article numbere105912
JournalEMBO Journal
Volume40
Issue number5
DOIs
Publication statusPublished - 1 Mar 2021

Research programs

  • EMC OR-01

Fingerprint

Dive into the research topics of 'An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells'. Together they form a unique fingerprint.

Cite this